Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| シリーズ: | Endocrinology Research and Practice |
| 主題: | |
| オンライン･アクセス: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|